1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow tafluprost: new trials by email Literature Review of tafluprost trials Research Report on tafluprost
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT DE-117, 0.0015% tafluprost, DE-117 and 0.0015% tafluprost - Glaucoma and Ocular Hypertension | Phase 1 / Phase 2 | Completed | Santen Inc. | 60 | 2012-07-01 | 2018-04-18 |
Glaucoma (1) · Ocular Hypertension (1)
Santen Inc. (1)
United States (1)